Results 111 to 120 of about 3,518 (203)

Diagnostic Efficacy of Plasma-Based Real-Time PCR for Schistosomiasis Japonica in Mice before and after Treatment with Praziquantel. [PDF]

Animals (Basel), 2023
Chen C, Zhou X, Guo Q, Lv C, Tang Y, Guo Q, Chen Y, Zhou K, Fu Z, Liu J, Lin J, Hong Y, Chen JH.   +12 more
europepmc   +1 more source

Human susceptibility to Schistosoma japonicum in China correlates with antibody isotypes to native antigens [PDF]

, 2017
Antibody isotypic responses (IgE, IgA, IgG1, IgG2, IgG3 and IgG4) to Schistosoma japonicum antigens—adult worm (AWA), soluble egg (SEA) and the recombinant proteins TEG (22·6-kDa tegumental antigen, Sj22) and PMY (paramyosin, Sj97)—were measured (in 1998)
Li, Yi, Li, Yuesheng, McManus, Donald P., Ross, Allen G.P., Sleigh, Adrian C., Tanner, Marcel, Williams, Gail M., Yu, Xinling, Zhang, Xinyue   +8 more
core  

Knocking Down Gm16685 Decreases Liver Granuloma in Murine Schistosomiasis Japonica. [PDF]

Microorganisms, 2023
Zhao R, Tang X, Lin H, Xing C, Xu N, Dai B, Wang P, Shao W, Liu M, Shen J, Deng S, Ren C.   +11 more
europepmc   +1 more source

Network Analysis and Nomogram in the Novel Classification and Prognosis Prediction of Advanced Schistosomiasis Japonica. [PDF]

Am J Trop Med Hyg, 2023
Liu XF, Li Y, Ju S, Zhou YL, Qiang JW.
europepmc   +1 more source

Liver morbidity due to Schistosoma mekongi in Cambodia after seven rounds of mass drug administration [PDF]

, 2017
Severe liver disease due to Schistosoma mekongi was frequent in northern Cambodia. Between 1995 and 2002, seven rounds of mass chemotherapy (praziquantel) reduced infection from 50% to below 3%. In 2002, we assessed hepatosplenic morbidity by historical,
Cheam, S., Degrémont, A., Hatz, C., Keang, H., Odermatt, P., Odermatt-Biays, S.   +5 more
core  

Schistosomiasis japonica transmission dynamics: mathematical modeling in guiding One Health approach control strategies. [PDF]

Infect Dis Poverty
Bansilan NP, Prada JM, Alonte AJI, Betson ME, Paller VGV, Rabajante JF.   +5 more
europepmc   +2 more sources

Two Molecular Plasma-Based Diagnostic Methods to Evaluate Early Infection of Schistosoma japonicum and Schistosomiasis Japonica. [PDF]

Microorganisms, 2023
Hong Y, Guo Q, Zhou X, Tang L, Chen C, Shang Z, Zhou K, Zhang Z, Liu J, Lin J, Xu B, Chen JH, Fu Z, Hu W.   +13 more
europepmc   +1 more source

Small change, big difference: A promising praziquantel derivative designated P96 with broad-spectrum antischistosomal activity for chemotherapy of schistosomiasis japonica. [PDF]

PLoS Negl Trop Dis, 2023
Xu J, Dong LL, Sun H, Huang P, Zhang RZ, Wang XY, Sun DQ, Xia CM.   +7 more
europepmc   +1 more source

Diagnostic performance of a urine-based ELISA assay for the screening of human schistosomiasis japonica: A comparative study. [PDF]

Front Microbiol, 2022
Mu Y, Weerakoon KG, Olveda RM, Ross AG, McManus DP, Cai P.   +5 more
europepmc   +1 more source

Elimination of Schistosomiasis Japonica in China: From the One Health Perspective. [PDF]

China CDC Wkly, 2022
Hong Z, Li L, Zhang L, Wang Q, Xu J, Li S, Zhou XN.   +6 more
europepmc   +1 more source